Tweet by Michael Okun on Twitter. Alzheimer’s drug Posted byJoseph Thornton MDSeptember 27, 2022Posted inBlog Michael Okun @MichaelOkun Huge Alzheimer’s news; new drug! Phase 3 confirmatory Clarity AD clinical trial of lecanemab, investigational anti-amyloid beta (Aβ) protofibril antibody, met primary endpoint (CDR-SB: Clinical Dementia Rating-Sum of Boxes) and key secondary endpoints. Great news! @FixelInstitute pic.twitter.com/vYSKJy9MX3 9/27/22, 8:47 PM Joseph Thornton Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Related Published by Joseph Thornton MD Teacher, Clinical Supervisor, [AIdvisor] Retired Clinical Associate Professor, Psychiatry, University of Florida Affiliation is for identification only. All content and opinions are my own. View more posts
Gator Psychiatry 